These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33447052)
1. Mechanisms and Functions of MiR-200 Family in Hepatocellular Carcinoma. Mao Y; Chen W; Wu H; Liu C; Zhang J; Chen S Onco Targets Ther; 2020; 13():13479-13490. PubMed ID: 33447052 [TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00460 conduces to tumor growth and metastasis of hepatocellular carcinoma through miR-342-3p-dependent AGR2 up-regulation. Hong H; Sui C; Qian T; Xu X; Zhu X; Fei Q; Yang J; Xu M Aging (Albany NY); 2020 Jun; 12(11):10544-10555. PubMed ID: 32493835 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance. Du Z; Niu S; Xu X; Xu Q Cancer Biomark; 2017; 19(2):221-230. PubMed ID: 28269758 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma. Wu J; Huang J; Wang W; Xu J; Yin M; Cheng N; Yin J Cancer Biomark; 2017 Jul; 20(1):55-65. PubMed ID: 28759956 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897 [TBL] [Abstract][Full Text] [Related]
8. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. Dang S; Zhou J; Wang Z; Wang K; Dai S; He S Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358 [TBL] [Abstract][Full Text] [Related]
9. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Wang F; Ying H; He B; Pan Y; Sun H; Wang S Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
11. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients. Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
13. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model. Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value. Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID. Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues. Zhang QH; Sun HM; Zheng RZ; Li YC; Zhang Q; Cheng P; Tang ZH; Huang F Gene; 2013 Sep; 527(1):26-32. PubMed ID: 23791657 [TBL] [Abstract][Full Text] [Related]
17. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
18. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation. Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928 [TBL] [Abstract][Full Text] [Related]
19. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241 [TBL] [Abstract][Full Text] [Related]
20. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma. Zhang C; Xia R; Zhang B; Wang H BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]